jRCT2031220674
Untitled Trial
A Phase 2 Open label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Astellas Pharma Global Development Inc.·Japan Registry Clinical TrialRecruiting
Study focus
- Disease/Condition
- Prostate cancer
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Astellas Pharma Global Development Inc.
- Location
- United States of America;Argentina;Australia;Belgium;Canada;Chile;Czech;Denmark;Finland;France;Georg
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Malignant neoplasm of prostateHyperplasia of prostateDisorder of prostate, unspecifiedOther disorders of prostateCarcinoma in situ: Prostate
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCT2031220674
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCT2031220674 through Pure Global AI's free database. This phase not specified trial is sponsored by Astellas Pharma Global Development Inc. and is currently Recruiting. The study focuses on Prostate cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.